ESG Risk Assessments and Insights Limited assigned Zydus Lifesciences an overall ESG rating of 68, an improvement from last year's score of 66.
The rating was independently prepared by ESGRAIL based on publicly available information and not commissioned by the company.
The disclosure was made to BSE and NSE in compliance with SEBI Listing Regulations and circulars dated November 2024 and December 2024.
The company received the ESG rating report via email on April 9, 2026, at 15:30 hours.